Femto Technologies Inc. has launched Sensera, its flagship tech-enabled intimacy device, in the United States. The device, now available for purchase at https://senserawellness.com, retails for $299 for the starter kit and represents a new standard in personal technology through its adaptive, data-informed approach to wellness.
The core innovation of Sensera is Femto's proprietary patented Smart Release System (SRS), which leverages integrated real-time physiological metrics such as heart rate and muscular activity. This system enables precise, adaptive performance tuned to each user's individual profile, marking a step forward in connected wellness technology. Over time, the device refines its responses through continuous use, creating a personalized experience that evolves with the user.
Through its dedicated iOS app, users can create customized programs that allow the device's machine-learning and advanced AI capabilities to continually enhance its performance and personalization. This integration of artificial intelligence with personal wellness devices represents a growing trend in the femtech industry, where technology is increasingly used to create tailored health and wellness solutions. Sensera's recognition as a CES Innovation Awards 2025 Honoree in the Artificial Intelligence category validates the technical sophistication behind this product.
"We're redefining the intersection of technology and personal wellness," said Yftah Ben Yaackov, CEO of Femto Technologies. "Sensera represents our vision of intelligent, user-centered innovation. This launch underscores our commitment to our investors and stakeholders, as well as our mission to bring cutting-edge femtech solutions to consumers worldwide."
The launch of Sensera has significant implications for both the femtech industry and the broader consumer technology market. For industry leaders, it demonstrates how artificial intelligence and machine learning can be applied to create highly personalized wellness products that adapt to individual user needs. The device's ability to learn from user data and refine its performance represents a shift toward more responsive and intelligent consumer health technology.
For the femtech sector specifically, Sensera's introduction signals continued innovation in a market that has seen substantial growth in recent years. The integration of physiological metrics with AI-driven personalization creates new possibilities for how technology can enhance personal wellness experiences. This development may prompt other companies in the space to invest more heavily in similar adaptive technologies, potentially accelerating innovation across the industry.
The regulatory and financial aspects of this launch are also noteworthy, as Femto Technologies is a publicly traded company listed on OTCQB under the symbol FMTOF. Investors can find detailed financial information in the company's filings, including its management's discussion and analysis for the year ended December 31, 2024 and annual information form dated March 31, 2025, available under the company's profile at https://www.sedarplus.ca, as well as in the Company's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission.
The broader impact of Sensera's launch extends to how businesses approach product development in the wellness technology space. The emphasis on data-informed personalization through AI represents a shift toward more sophisticated, user-centric design that could influence product development across multiple technology sectors. As consumers increasingly expect personalized experiences from their devices, technologies like Sensera's Smart Release System may become more commonplace in various consumer electronics categories.
